Analysts have raised their price target for Healthcare Realty Trust from $17.75 to $18.56. They cite incremental improvements in fair value estimates based on modest adjustments to the discount rate and updated profit margin projections.
What's in the News
- The company has completed the repurchase of 3,679,162 shares, representing 1.03% of shares outstanding, for a total of $63.04 million under the buyback program announced on October 30, 2024 (Key Developments).
- The Board approved a common stock dividend of $0.24 per share and the same distribution per operating partnership unit. The dividend is payable on August 28, 2025, to Class A common stockholders of record as of August 14, 2025 (Key Developments).
- Healthcare Realty Trust lowered its 2025 earnings guidance and now expects a loss per share between $0.78 and $0.73, compared to previous estimates of a $0.28 to $0.20 loss per share (Key Developments).
- Reported impairments of real estate assets for the second quarter ended June 30, 2025, reached $140,877,000, up from $120,917,000 the previous year (Key Developments).
Valuation Changes
- Consensus Analyst Price Target has risen slightly, moving from $17.75 to $18.56.
- Discount Rate fell marginally, decreasing from 8.28% to 8.27%.
- Revenue Growth estimate remains nearly flat, shifting minimally from -1.15% to -1.15%.
- Net Profit Margin decreased modestly, changing from 23.33% to 23.08%.
- Future P/E ratio increased, moving from 28.48x to 29.64x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.